Connect Biopharma Holdings Ltd (CNTB) Straddle

Trading a CNTB straddle lets you take a pure volatility position on Connect Biopharma Holdings Ltd without committing to a direction. Connect Biopharma Holdings Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CNTB straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on CNTB profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Connect Biopharma Holdings Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CNTB straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation.

The company was founded in 2012 and is headquartered in Taicang, China.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the CNTB straddle is the cleanest expression of that view. Our scanner prices every CNTB straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CNTB straddle into a catalyst or short a CNTB straddle to harvest decay, the options straddle setups that matter are all in one place.